PubMed

Case 19-2009: Carcinoma of the gastroesophageal junction.

van der Vliet HJ, van der Peet DL, Verheul HM.

N Engl J Med. 2009 Sep 24;361(13):1315; author reply 1315-6. No abstract available. PMID: 19776417 [PubMed - indexed for MEDLINE]Related articles

Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

Song W, van der Vliet HJ, Tai YT, Prabhala R, Wang R, Podar K, Catley L, Shammas MA, Anderson KC, Balk SP, Exley MA, Munshi NC.

Clin Cancer Res. 2008 Nov 1;14(21):6955-62.PMID: 18980990 [PubMed - indexed for MEDLINE]Related articlesFree article

Invariant natural killer T cells and immunotherapy of cancer.

Molling JW, Moreno M, van der Vliet HJ, van den Eertwegh AJ, Scheper RJ, von Blomberg BM, Bontkes HJ.

Clin Immunol. 2008 Nov;129(2):182-94. Epub 2008 Sep 9. Review.PMID: 18783990 [PubMed - indexed for MEDLINE]Related articles

Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells.

van der Vliet HJ, Wang R, Yue SC, Koon HB, Balk SP, Exley MA.

J Immunol. 2008 Jun 1;180(11):7287-93.PMID: 18490728 [PubMed - indexed for MEDLINE]Related articlesFree article

[A patient with very high serum level of human chorionic gonadotrophin; the diagnosis is not always a germ-cell tumour]

van der Vliet HJ, Lefesvre P, van Groeningen CJ.

Ned Tijdschr Geneeskd. 2008 Mar 22;152(12):705-9. Dutch. PMID: 18438068 [PubMed - indexed for MEDLINE]Related articles

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases.

Molling JW, Moreno M, de Groot J, van der Vliet HJ, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ.

Immunol Lett. 2008 Jun 15;118(1):36-43. Epub 2008 Mar 24.PMID: 18405982 [PubMed - indexed for MEDLINE]Related articles

IPEX as a result of mutations in FOXP3.

van der Vliet HJ, Nieuwenhuis EE.

Clin Dev Immunol. 2007;2007:89017. Review.PMID: 18317533 [PubMed - indexed for MEDLINE]Related articlesFree article

[Myocardial ischaemia as a result of treatment with capecitabine]

van der Vliet HJ, Kuenen BC.

Ned Tijdschr Geneeskd. 2007 Sep 8;151(36):2016; author reply 2016. Dutch. No abstract available. PMID: 17953177 [PubMed - indexed for MEDLINE]Related articles

Exploiting regulatory T-cell populations for the immunotherapy of cancer.

van der Vliet HJ, Koon HB, Atkins MB, Balk SP, Exley MA.

J Immunother. 2007 Sep;30(6):591-5. Review.PMID: 17667522 [PubMed - indexed for MEDLINE]Related articles

Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.

Veldt BJ, van der Vliet HJ, von Blomberg BM, van Vlierberghe H, Gerken G, Nishi N, Hayashi K, Scheper RJ, de Knegt RJ, van den Eertwegh AJ, Janssen HL, van Nieuwkerk CM.

J Hepatol. 2007 Sep;47(3):356-65. Epub 2007 Jun 6.PMID: 17599630 [PubMed - indexed for MEDLINE]Related articles

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.

van der Vliet HJ, Koon HB, Yue SC, Uzunparmak B, Seery V, Gavin MA, Rudensky AY, Atkins MB, Balk SP, Exley MA.

Clin Cancer Res. 2007 Apr 1;13(7):2100-8. Erratum in: Clin Cancer Res. 2007 Jun 1;13(11):3433. van der Vliet, Hans J J [corrected to van der Vliet, Hans J]. PMID: 17404092 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses.

Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ.

J Virol. 2007 Jun;81(11):5882-92. Epub 2007 Mar 21.PMID: 17376924 [PubMed - indexed for MEDLINE]Related articlesFree article

Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.

Molling JW, Moreno M, van der Vliet HJ, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ.

J Immunol Methods. 2007 Apr 30;322(1-2):70-81. Epub 2007 Feb 23.PMID: 17343874 [PubMed - indexed for MEDLINE]Related articles

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.

Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, von Blomberg BM, Scheper RJ, van den Eertwegh AJ.

J Clin Oncol. 2007 Mar 1;25(7):862-8.PMID: 17327607 [PubMed - indexed for MEDLINE]Related articles

Natural killer T cell-based cancer immunotherapy.

van der Vliet HJ, Balk SP, Exley MA.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5921-3. No abstract available. PMID: 17062661 [PubMed - indexed for MEDLINE]Related articlesFree article

Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection.

van der Vliet HJ, van Vonderen MG, Molling JW, Bontkes HJ, Reijm M, Reiss P, van Agtmael MA, Danner SA, van den Eertwegh AJ, von Blomberg BM, Scheper RJ.

J Immunol. 2006 Nov 1;177(9):5775-8.PMID: 17056500 [PubMed - indexed for MEDLINE]Related articlesFree article

Schistosomiasis.

van der Vliet HJ, van Kemenade FJ, Hekker TA, Craanen ME.

Clin Gastroenterol Hepatol. 2005 Jun;3(6):A26. No abstract available. PMID: 15952091 [PubMed - indexed for MEDLINE]Related articles

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.

Molling JW, Kölgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, van den Eertwegh AJ.

Int J Cancer. 2005 Aug 10;116(1):87-93.PMID: 15756674 [PubMed - indexed for MEDLINE]Related articles

Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.

van der Vliet HJ, Molling JW, von Blomberg BM, Kölgen W, Stam AG, de Gruijl TD, Mulder CJ, Janssen HL, Nishi N, van den Eertwegh AJ, Scheper RJ, van Nieuwkerk CJ.

Clin Immunol. 2005 Feb;114(2):183-9.PMID: 15639652 [PubMed - indexed for MEDLINE]Related articles

Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis.

van der Vliet HJ, Perenboom RM.

Ann Intern Med. 2004 Dec 7;141(11):896-7. No abstract available. PMID: 15583245 [PubMed - indexed for MEDLINE]Related articlesFree article

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kölgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ.

Clin Immunol. 2004 Jul;112(1):8-23. Review.PMID: 15207777 [PubMed - indexed for MEDLINE]Related articles

[Megacolon during treatment with lactulose]

van der Vliet HJ, van Bodegraven AA.

Ned Tijdschr Geneeskd. 2004 May 15;148(20):998-1001. Dutch. PMID: 15181726 [PubMed - indexed for MEDLINE]Related articles

Myocardial air collections as a result of infection with a gas producing strain of Escherichia coli.

van der Vliet HJ, Niessen HW, Perenboom RM.

J Clin Pathol. 2004 Jun;57(6):660-1.PMID: 15166278 [PubMed - indexed for MEDLINE]Related articlesFree article

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.

van der Vliet HJ, Molling JW, Nishi N, Masterson AJ, Kölgen W, Porcelli SA, van den Eertwegh AJ, von Blomberg BM, Pinedo HM, Giaccone G, Scheper RJ.

Cancer Res. 2003 Jul 15;63(14):4101-6.PMID: 12874013 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M, von Blomberg BM, Scheper RJ, van der Vliet HJ, van den Eertwegh AJ, Roelvink M, Beijnen J, Zwierzina H, Pinedo HM.

Clin Cancer Res. 2002 Dec;8(12):3702-9.PMID: 12473579 [PubMed - indexed for MEDLINE]Related articlesFree article

Natural Killer T cells.

van der Vliet HJ, Pinedo HM, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Giaccone G.

Lancet Oncol. 2002 Sep;3(9):574. No abstract available. PMID: 12217795 [PubMed - indexed for MEDLINE]Related articles

MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.

Masterson AJ, Sombroek CC, De Gruijl TD, Graus YM, van der Vliet HJ, Lougheed SM, van den Eertwegh AJ, Pinedo HM, Scheper RJ.

Blood. 2002 Jul 15;100(2):701-3.PMID: 12091369 [PubMed - indexed for MEDLINE]Related articlesFree article

A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient.

van der Vliet HJ, van Oers MH, Schot LJ, Majoie CB, van der Meer JT.

Ann Hematol. 2002 Mar;81(3):164-6. Epub 2002 Feb 23.PMID: 11904744 [PubMed - indexed for MEDLINE]Related articles

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

van der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJ, Giaccone G, Miedema F, Scheper RJ, Pinedo HM.

J Immunol. 2002 Feb 1;168(3):1490-5.PMID: 11801694 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.

van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, Polman CH, Rustemeyer T, Lips P, van den Eertwegh AJ, Giaccone G, Scheper RJ, Pinedo HM.

Clin Immunol. 2001 Aug;100(2):144-8.PMID: 11465942 [PubMed - indexed for MEDLINE]Related articles

Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.

van der Vliet HJ, Nishi N, Koezuka Y, von Blomberg BM, van den Eertwegh AJ, Porcelli SA, Pinedo HM, Scheper RJ, Giaccone G.

J Immunol Methods. 2001 Jan 1;247(1-2):61-72.PMID: 11150537 [PubMed - indexed for MEDLINE]Related articles

Human natural killer T cells acquire a memory-activated phenotype before birth.

van Der Vliet HJ, Nishi N, de Gruijl TD, von Blomberg BM, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ.

Blood. 2000 Apr 1;95(7):2440-2.PMID: 10733519 [PubMed - indexed for MEDLINE]Related articlesFree article

Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.

Nishi N, van der Vliet HJ, Koezuka Y, von Blomberg BM, Scheper RJ, Pinedo HM, Giaccone G.

Hum Immunol. 2000 Apr;61(4):357-65.PMID: 10715513 [PubMed - indexed for MEDLINE]Related articles

All-trans-retinoic acid-induced myositis: a description of two patients.

van Der Vliet HJ, Roberson AE, Hogan MC, Morales CE, Crader SC, Letendre L, Pruthi RK.

Am J Hematol. 2000 Feb;63(2):94-8.PMID: 10629576 [PubMed - indexed for MEDLINE]Related articles

Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.

Van Der Vliet HJ, Nishi N, Koezuka Y, Peyrat MA, Von Blomberg BM, Van Den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ.

Immunology. 1999 Dec;98(4):557-63.PMID: 10594688 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of granzyme B during primary cytomegalovirus infection after renal transplantation.

Wever PC, Spaeny LH, van der Vliet HJ, Rentenaar RJ, Wolbink AM, Surachno J, Wertheim PM, Schellekens PT, Hack CE, ten Berge IJ.

J Infect Dis. 1999 Mar;179(3):693-6.PMID: 9952379 [PubMed - indexed for MEDLINE]Related articles

The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

Wever PC, Van Der Vliet HJ, Spaeny LH, Wolbink AM, Van Diepen FN, Froelich CJ, Hack CE, ten Berge IJ.

Immunology. 1998 Mar;93(3):383-9.PMID: 9640249 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis.

Van Der Vliet HJ, Wever PC, Van Diepen FN, Yong SL, Ten Berge IJ.

Clin Exp Immunol. 1997 Nov;110(2):324-8.PMID: 9367420 [PubMed - indexed for MEDLINE]Related articlesFree article